A follow up on the feasibility after national implementation of magnesium sulfate for neuroprotection prior to preterm birth.
Hellström S, Jonsdotter A, Jonsson M, Pettersson K, Saltvedt S, Herbst A, Ågren J, Ådén U, Domellöf M, Hagberg H, Carlsson Y.
Hellström S, et al.
Acta Obstet Gynecol Scand. 2023 Dec;102(12):1741-1748. doi: 10.1111/aogs.14673. Epub 2023 Sep 8.
Acta Obstet Gynecol Scand. 2023.
PMID: 37680134
Free PMC article.
Prenatal administration of magnesium sulfate (MgSO(4) ) has been shown to be neuroprotective and reduces the proportion of very preterm born children later diagnosed with cerebral palsy. A Swedish national clinical practice guideline was implemented in March 2020, stipulat …
Prenatal administration of magnesium sulfate (MgSO(4) ) has been shown to be neuroprotective and reduces the proportion of very preterm born …